BioMérieux S.A.
BIM
Rang in aandelen
#1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aandeelprijs
$103.91
Marktkapitalisatie
$12.23B
Verandering (1 dag)
0.86%
Verandering (1 jaar)
-19.74%
Land
FR
Handel BioMérieux S.A. (BIM)
Categorie
Healthcare
Winst voor BioMérieux S.A. (BIM)
Winst in Jun 2026 TTM: $720.00M
Volgens de meest recente financiële verslagen van BioMérieux S.A. bedraagt de huidige winst van het bedrijf $720.00M. In 2023 behaalde het bedrijf een winst van $483.64M, een daling ten opzichte van de winst van 2022, die $590.19M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van BioMérieux S.A. van 2005 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $720.00M | 19.44% |
| 2024 | $602.80M | 24.64% |
| 2023 | $483.64M | -18.05% |
| 2022 | $590.19M | -30.64% |
| 2021 | $850.93M | 41.32% |
| 2020 | $602.12M | 68.44% |
| 2019 | $357.47M | -2.94% |
| 2018 | $368.30M | 5.12% |
| 2017 | $350.37M | 28.57% |
| 2016 | $272.52M | 42.44% |
| 2015 | $191.32M | -15.53% |
| 2014 | $226.50M | -32.25% |
| 2013 | $334.30M | 13.34% |
| 2012 | $294.95M | -4.15% |
| 2011 | $307.71M | -4.66% |
| 2010 | $322.75M | 11.10% |
| 2009 | $290.50M | 14.03% |
| 2008 | $254.76M | 12.73% |
| 2007 | $225.98M | 12.99% |
| 2006 | $200.00M | 22.21% |
| 2005 | $163.65M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 956.81% |
US
|
|
| $4.76B | 561.39% |
US
|
|
| $-252.70M | -135.10% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 130.28% |
US
|
